Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Platelet rich plasma is an effective treatment for alopecia areata.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Combining ciclosporin and simvastatin can cause severe kidney damage.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Lower BDNF levels link to worse depression in alopecia areata patients.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Certain gene variations may increase the risk and severity of alopecia areata.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Vitamin D receptor gene changes don't affect alopecia areata risk.